Cover Image
Market Research Report

Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Technology (CTC Detection & Enrichment Methods, CTC Analysis), By Application, By Product, By Specimen, By Region, And Segment Forecasts, 2020 - 2027

Published by Grand View Research, Inc. Product code 636667
Published Content info 220 Pages
Delivery time: 2-3 business days
Price
Back to Top
Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Technology (CTC Detection & Enrichment Methods, CTC Analysis), By Application, By Product, By Specimen, By Region, And Segment Forecasts, 2020 - 2027
Published: April 2, 2020 Content info: 220 Pages
Description

The global circulating tumor cell market size is expected to reach around USD 23.9 billion by 2027 at a CAGR of 13.2% over the forecast period, according to a new report by Grand View Research, Inc. The growth in cancer-related spending for the introduction of companion diagnostics and targeted therapies has driven the circulating tumor cell (CTC) market over the past years. Research organizations are engaged in endeavors aimed at developing circulating tumor cells based tests to improve cancer diagnosis in terms of efficiency and speed.

Furthermore, the growing demand for minimally invasive diagnostic procedures is anticipated to propel investments by key stakeholders in this area. Circulating tumor cell based liquid biopsy tests lead to limited trauma and enable rapid recovery owing to their non-invasive nature. Moreover, it enables minimal invasive screening of tumors before opting for complex surgical procedures, such as radiotherapy, chemotherapy, and surgical removal of tumors, thus positively impacting the adoption.

The limited applicability of these cells in rare cancers has hampered the revenue growth up to a certain extent. For instance, there is a negligible evidence for the characterization of circulating tumor cells for sarcoma. Conversely, several methods are being investigated for isolation of these cells, such as methods based on epithelial antigen-targeted antibodies, which are anticipated to help overcome these challenges in the coming years.

Further key findings from the report suggest:

CTC detection and enrichment methods accounted for the largest revenue share owing to the presence of wide availability of products for CTC enrichment and isolation

Moreover, high penetration in terms of usage of products offered under this segment has driven the segment share

Growing application of nanomaterials in cancer management is anticipated to drive revenue for direct detection methods in the coming years

Devices and systems dominated the revenue share in 2019 over its counterpart segments including kits and reagents and blood collection tubes

Presence of high-throughput automated systems coupled with the availability of a substantial number of systems to carry out detection of tumor cells has contributed to large revenue share

CTC analysis has major applications in research settings, including investigational research, drug developments, and biomarker studies. This has resulted in a segment's large revenue share

Currently, whole blood specimens are the key source of CTCs, thus accounting for the largest share in 2019

Low use of bone marrow-derived cells in clinical settings has contributed to a smaller revenue share of this segment

Other sources include CSF, spinal fluids, urine, and pleural effusion

Easy availability of biological specimens, such as urine, is likely to accelerate adoption under this segment

The CTC market is fragmented in nature with the presence of well-established players, along with medium to small-sized players

Some players operating in the space are QIAGEN; Greiner Bio One International GmbH; Menarini Silicon Biosystems; Sysmex Corporation; Bio-Techne Corporation; and Biocept, Inc.

Table of Contents
Product Code: 978-1-68038-287-7

Table of contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation
  • 1.4 Market Scope & Segment Definition
    • 1.4.1 Technology scope
      • 1.4.1.1 CTC detection & enrichment methods
      • 1.4.1.2 CTC direct detection methods
      • 1.4.1.3 CTC analysis
    • 1.4.2 Application scope
      • 1.4.2.1 Clinical/liquid biopsy
      • 1.4.2.2 Research
    • 1.4.3 Product Scope
    • 1.4.4 Specimen scope
  • 1.5 Market Model
    • 1.5.1 Segment analysis
      • 1.5.1.1 Technology
      • 1.5.1.2 Product
      • 1.5.1.3 Application
      • 1.5.1.4 Specimen
    • 1.5.2 Regional analysis

Chapter 2 Executive Summary

  • 2.1 Market Snapshot (USD Million, 2019)

Chapter 3 Circulating Tumor Cells (CTCs) Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
      • 3.1.1.1 Molecular applications of liquid biopsy for personalized medicine
    • 3.1.2 Related/ancillary market outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market driver analysis
      • 3.2.1.1 Advancements in chip technology
      • 3.2.1.2 Expanding applications of CTCs
      • 3.2.1.3 Growing demand for early and rapid cancer diagnosis
      • 3.2.1.4 Growing incidence of cancer
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 Consistency-related challenges in CTC detection and enrichment
      • 3.2.2.2 Higher preference for Point-of-Care (POC) testing and non-availability of POC adaptable CTC tests
      • 3.2.2.3 Lower applicability of CTCs in rare cancers
  • 3.3 Challenge Analysis
    • 3.3.1 Challenges in detection of circulating tumor cells in sarcoma
  • 3.4 Penetration & Growth Prospect Mapping, Technology, 2019
  • 3.5 Pipeline Analysis
  • 3.6 Technology Overview
    • 3.6.1 Technology timeline
  • 3.7 Market entry strategies
    • 3.7.1 Acquisition
    • 3.7.2 Joint venture
    • 3.7.3 Partnership and collaboration
  • 3.8 User Perspective Analysis
    • 3.8.1 Consumer behavior analysis
    • 3.8.2 Market influencer analysis
    • 3.8.3 Procedure cost analysis/breakdown
  • 3.9 Regulatory Framework
    • 3.9.1 Reimbursement framework
    • 3.9.2 Standards & compliances
  • 3.10 Case studies
    • 3.10.1 Dissolution-enhanced time-resolved photoluminescence for direct detection of CTCs in blood
    • 3.10.2 Integrated Microfluidic Device for Enrichment and Identification of Circulating Tumor Cells from the Blood of Patients with Colorectal Cancer

Chapter 4 Circulating Tumor Cells (CTCs) Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Company/Competition Categorization
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
  • 4.4 Key Company Market Ranking, 2019
    • 4.4.1 Company financial size
    • 4.4.2 Product portfolio
    • 4.4.3 Geographic footprint
    • 4.4.4 Innovation
    • 4.4.5 Pipeline
    • 4.4.6 Strategic initiatives
  • 4.5 Public Companies
    • 4.5.1 Company market position analysis
      • 4.5.1.1 Number of products
      • 4.5.1.2 Market penetration
      • 4.5.1.3 Strategic initiatives
      • 4.5.1.4 Segment coverage
      • 4.5.1.5 Geographical presence
    • 4.5.2 Competitive dashboard analysis
    • 4.5.3 Market differentiators
  • 4.6 Private Companies
    • 4.6.1 List of key emerging companies
    • 4.6.2 Regional network map
    • 4.6.3 Company market position analysis
    • 4.6.4 List of suppliers
  • 4.7 Major Deals & Strategic Alliances Analysis
    • 4.7.1 Joint ventures
    • 4.7.2 Licensing & partnership
    • 4.7.3 Mergers & acquisitions
    • 4.7.4 Technology collaborations
    • 4.7.5 Strategic divestments

Chapter 5 Circulating Tumor Cells (CTCs) Market: Technology Estimates & Trend Analysis

  • 5.1 Circulating Tumor Cells (CTCs) Market: Technology Movement Analysis
  • 5.2 CTC Enrichment & Detection
    • 5.2.1 CTC enrichment & detection market, 2016 - 2027 (USD Million)
    • 5.2.2 Immunocapture/label-based
      • 5.2.2.1 Immunocapture (label-based) CTC market, 2016 - 2027 (USD Million)
      • 5.2.2.2 Immunocapture (label-based positive selection)
      • 5.2.2.2.1 Immunocapture (label-based positive selection) market, 2016 - 2027 (USD Million)
      • 5.2.2.3 Immunocapture (label-based) negative selection
      • 5.2.2.3.1 Immunocapture (label-based) negative selection market, 2016 - 2027 (USD Million)
    • 5.2.3 Size-based separation/label-free
      • 5.2.3.1 Size-based separation (label-free) CTC market, 2016 - 2027 (USD Million)
      • 5.2.3.2 Membrane-based size separation (label-free)
      • 5.2.3.2.1 Membrane-based size separation(label-free) CTC market, 2016 - 2027 (USD Million)
      • 5.2.3.3 Microfluidic-based size separation (label-free)
      • 5.2.3.3.1 Microfluidic-based size separation (label-free) CTC market, 2016 - 2027 (USD Million)
    • 5.2.4 Density-based separation (label-free)
      • 5.2.4.1 Density-based separation (label-free) CTC market, 2016 - 2027 (USD Million)
    • 5.2.5 Combined methods (label-free)
      • 5.2.5.1 Combined methods (label-free) CTC market, 2016 - 2027 (USD Million)
  • 5.3 CTC Direct Detection
    • 5.3.1 CTC direct detection market, 2016 - 2027 (USD Million)
    • 5.3.2 Microscopy
      • 5.3.2.1 CTC microscopy direct detection market, 2016 - 2027 (USD Million)
    • 5.3.3 SERS
      • 5.3.3.1 CTC SERS direct detection market, 2016 - 2027 (USD Million)
    • 5.3.4 Others
      • 5.3.4.1 CTC Other direct detection market, 2016 - 2027 (USD Million)
  • 5.4 CTC Analysis & Downstream Assays
    • 5.4.1 CTC analysis & downstream assays market, 2016 - 2027 (USD Million)

Chapter 6 Circulating Tumor Cells (CTCs) Market Categorization: Application Estimates & Trend Analysis

  • 6.1 Global Circulating Tumor Cells (CTCs) Market: Application Movement Analysis, 2019 & 2025
  • 6.2 Clinical/Liquid Biopsy
    • 6.2.1 Circulating tumor cells market for clinical/liquid biopsy, 2016 - 2027 (USD Million)
    • 6.2.2 Risk assessment
      • 6.2.2.1 Circulating tumor cells market for risk assessment, 2016 - 2027 (USD Million)
    • 6.2.3 Screening and monitoring
      • 6.2.3.1 Circulating tumor cells market for screening and monitoring, 2016 - 2027 (USD Million)
  • 6.3 Research
    • 6.3.1 Circulating tumor cells market for research, 2016 - 2027 (USD Million)
    • 6.3.2 Cancer stem cell & tumorigenesis research
      • 6.3.2.1 Circulating tumor cells market for cancer stem cell & tumorigenesis research, 2016 - 2027 (USD Million)
    • 6.3.3 Drug/therapy development
      • 6.3.3.1 Circulating tumor cells market for drug/therapy development, 2016 - 2027 (USD Million)

Chapter 7 Circulating Tumor Cells (CTCs) Market Categorization: Product Estimates & Trend Analysis

  • 7.1 Global Circulating Tumor Cells (CTCs) Market: Product Movement Analysis, 2019 & 2025
  • 7.2 Devices or Systems
    • 7.2.1 Global devices or systems market, 2016 - 2027 (USD Million)
  • 7.3 Kits & Reagents
    • 7.3.1 Global kits and reagents market, 2016 - 2027 (USD Million)
  • 7.4 Blood Collection Tubes
    • 7.4.1 Global blood collection tubes market, 2016 - 2027 (USD Million)

Chapter 8 Circulating Tumor Cells (CTCs) Market Categorization: Specimen Estimates & Trend Analysis

  • 8.1 Blood
    • 8.1.1 Global blood based CTC specimen market, 2016 - 2027 (USD Million)
  • 8.2 Bone Marrow
    • 8.2.1 Global bone marrow based CTC specimen market, 2016 - 2027 (USD Million)
  • 8.3 Other Body Fluids
    • 8.3.1 Global other body fluids based CTC specimen market, 2016 - 2027 (USD Million)

Chapter 9 Circulating Tumor Cells (CTCs) Market: Regional Estimates & Trend Analysis, by Technology, Product, Application, and Specimen

  • 9.1 Circulating Tumor Cells (CTCs) Market Share By Regional, 2019 & 2027
  • 9.2 North America
    • 9.2.1 North America Circulating Tumor Cells (CTCs) market, 2016 - 2027 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.2.2.2 U.S. Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.2.2.3 U.S. Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.2.2.4 U.S. Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.2.3.2 Canada Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.2.3.3 Canada Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.2.3.4 Canada Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe Circulating Tumor Cells (CTCs) market, 2016 - 2027 (USD Million)
    • 9.3.2 U.K.
      • 9.3.2.1 U.K. Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.3.2.2 U.K. Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.3.2.3 U.K. Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.3.2.4 U.K. Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.3.3 France
      • 9.3.3.1 France Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.3.3.2 France Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.3.3.3 France Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.3.3.4 France Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.3.4 Italy
      • 9.3.4.1 Italy Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.3.4.2 Italy Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.3.4.3 Italy Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.3.4.4 Italy Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.3.5 Germany
      • 9.3.5.1 Germany Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.3.5.2 Germany Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.3.5.3 Germany Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.3.5.4 Germany Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.3.6 Spain
      • 9.3.6.1 Spain Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.3.6.2 Spain Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.3.6.3 Spain Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.3.6.4 Spain Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Circulating Tumor Cells (CTCs) market, 2016 - 2027 (USD Million)
    • 9.4.2 China
      • 9.4.2.1 China Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.4.2.2 China Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.4.2.3 China Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.4.2.4 China Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.4.3 Japan
      • 9.4.3.1 Japan Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.4.3.2 Japan Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.4.3.3 Japan Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.4.3.4 Japan Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.4.4.2 India Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.4.4.3 India Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.4.4.4 India Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.4.5 South Korea
      • 9.4.5.1 South Korea Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.4.5.2 South Korea Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.4.5.3 South Korea Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.4.5.4 South Korea Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.4.6 Singapore
      • 9.4.6.1 Singapore Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.4.6.2 Singapore Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.4.6.3 Singapore Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.4.6.4 Singapore Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.4.7 Australia
      • 9.4.7.1 Australia Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.4.7.2 Australia Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.4.7.3 Australia Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.4.7.4 Australia Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America Circulating Tumor Cells (CTCs) market, 2016 - 2027 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.5.2.2 Brazil Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.5.2.3 Brazil Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.5.2.4 Brazil Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.5.3 Argentina
      • 9.5.3.1 Argentina Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.5.3.2 Argentina Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.5.3.3 Argentina Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.5.3.4 Argentina Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
  • 9.6 Middle East & Africa (MEA)
    • 9.6.1 MEA Circulating Tumor Cells (CTCs) market, 2016 - 2027 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.6.2.2 South Africa Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.6.2.3 South Africa Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.6.2.4 South Africa Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)
    • 9.6.3 UAE
      • 9.6.3.1 UAE Circulating Tumor Cells (CTCs) market, by technology, 2016 - 2027 (USD Million)
      • 9.6.3.2 UAE Circulating Tumor Cells (CTCs) market, by product, 2016 - 2027 (USD Million)
      • 9.6.3.3 UAE Circulating Tumor Cells (CTCs) market, by application, 2016 - 2027 (USD Million)
      • 9.6.3.4 UAE Circulating Tumor Cells (CTCs) market, by specimen, 2016 - 2027 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 QIAGEN
    • 10.1.1 Company overview
    • 10.1.2 Financial performance
    • 10.1.3 Product benchmarking
    • 10.1.4 Strategic initiatives
  • 10.2 Bio-Techne Corporation
    • 10.2.1 Company overview
    • 10.2.2 Financial performance
    • 10.2.3 Product benchmarking
    • 10.2.4 Strategic initiatives
  • 10.3 Advanced Cell Diagnostics, Inc.
    • 10.3.1 Company overview
    • 10.3.2 Financial performance
    • 10.3.3 Product benchmarking
    • 10.3.4 Strategic initiatives
  • 10.4 Precision for Medicine
    • 10.4.1 Company overview
    • 10.4.2 Financial performance
    • 10.4.3 Product benchmarking
    • 10.4.4 Strategic initiatives
  • 10.5 ApoCell, Inc.
    • 10.5.1 Company overview
    • 10.5.2 Financial performance
    • 10.5.3 Product benchmarking
    • 10.5.4 Strategic initiatives
  • 10.6 Aviva Biosciences
    • 10.6.1 Company overview
    • 10.6.2 Financial performance
    • 10.6.3 Product benchmarking
    • 10.6.4 Strategic initiatives
  • 10.7 BIOCEPT, INC.
    • 10.7.1 Company overview
    • 10.7.2 Financial performance
    • 10.7.3 Product benchmarking
    • 10.7.4 Strategic initiatives
  • 10.8 BioCep Ltd.
    • 10.8.1 Company overview
    • 10.8.2 Financial performance
    • 10.8.3 Product benchmarking
    • 10.8.4 Strategic initiatives
  • 10.9 Fluxion Biosciences, Inc.
    • 10.9.1 Company overview
    • 10.9.2 Financial performance
    • 10.9.3 Product benchmarking
    • 10.9.4 Strategic initiatives
  • 10.10 Greiner Bio One International GmbH
    • 10.10.1 Company overview
    • 10.10.2 Financial performance
    • 10.10.3 Product benchmarking
    • 10.10.4 Strategic initiatives
  • 10.11 Ikonisys Inc.
    • 10.11.1 Company overview
    • 10.11.2 Financial performance
    • 10.11.3 Product benchmarking
    • 10.11.4 Strategic initiatives
  • 10.12 IVDiagnostics
    • 10.12.1 Company overview
    • 10.12.2 Product benchmarking
    • 10.12.3 Strategic initiatives
  • 10.13 Miltenyi Biotec
    • 10.13.1 Company overview
    • 10.13.2 Financial performance
    • 10.13.3 Product benchmarking
  • 10.14 NanoString Technologies, Inc.
    • 10.14.1 Company overview
    • 10.14.2 Financial performance
    • 10.14.3 Product benchmarking
  • 10.15 BioFluidica
    • 10.15.1 Company overview
    • 10.15.2 Financial performance
    • 10.15.3 Product benchmarking
    • 10.15.4 Strategic initiatives
  • 10.16 Canopus Bioscience Ltd.
    • 10.16.1 Company overview
    • 10.16.2 Product benchmarking
  • 10.17 Biolidics Limited
    • 10.17.1 Company overview
    • 10.17.2 Financial performance
    • 10.17.3 Product benchmarking
    • 10.17.4 Strategic initiatives
  • 10.18 Creatv MicroTech, Inc.
    • 10.18.1 Company overview
    • 10.18.2 Financial performance
    • 10.18.3 Product benchmarking
    • 10.18.4 Strategic initiatives
  • 10.19 LungLife AI, Inc.
    • 10.19.1 Company overview
    • 10.19.2 Financial performance
    • 10.19.3 Product benchmarking
    • 10.19.4 Strategic initiatives
  • 10.20 Epic Sciences
    • 10.20.1 Company overview
    • 10.20.2 Financial performance
    • 10.20.3 Product benchmarking
    • 10.20.4 Strategic initiatives
  • 10.21 Rarecells Diagnostics
    • 10.21.1 Company overview
    • 10.21.2 Financial performance
    • 10.21.3 Product benchmarking
  • 10.22 ScreenCell
    • 10.22.1 Company overview
    • 10.22.2 Financial performance
    • 10.22.3 Product benchmarking
  • 10.23 Menarini Silicon Biosystems
    • 10.23.1 Company overview
    • 10.23.2 Financial performance
    • 10.23.3 Product benchmarking
    • 10.23.4 Strategic initiatives
  • 10.24 Vitatex, Inc
    • 10.24.1 Company overview
    • 10.24.2 Product benchmarking
    • 10.24.3 Strategic initiatives
  • 10.25 Sysmex Corporation
    • 10.25.1 Company overview
    • 10.25.2 Financial performance
    • 10.25.3 Product benchmarking
    • 10.25.4 Strategic initiatives
  • 10.26 STEMCELL Technologies, Inc.
    • 10.26.1 Company overview
    • 10.26.2 Financial performance
    • 10.26.3 Product benchmarking
    • 10.26.4 Strategic initiatives

List of Tables

  • TABLE 1 Products for CTC detection & enrichment
  • TABLE 2 Products for CTC analysis by application
  • TABLE 3 Currently available methods for CTC analysis from whole blood
  • TABLE 4 Comparison of features of currently available CTC methods that use whole blood with the only FDA-approved technique
  • TABLE 5 Pipeline of Oncolys BioPharma, Inc. for CTC detection
  • TABLE 6 Pipeline of ANGLE plc for CTC detection
  • TABLE 7 Phase 1 clinical trials for circulating tumor cells
  • TABLE 8 Phase 2 clinical trials for circulating tumor cells
  • TABLE 9 Phase 3 clinical trials for circulating tumor cells
  • TABLE 10 Phase 4 clinical trials for circulating tumor cells
  • TABLE 11 CTC cluster separation platforms
  • TABLE 12 Medicare Clinical Laboratory Fee Schedule for CTC testing
  • TABLE 13 Reimbursement for CELLSEARCH Circulating Tumor Cell Test in the U.S.
  • TABLE 14 List of distributors and channel partners
  • TABLE 15 Regional network mapping: Private companies
  • TABLE 16 List of suppliers
  • TABLE 17 Frequently used CTC-positive enrichment techniques across clinical settings
  • TABLE 18 Frequently used CTC negative enrichment techniques across clinical settings
  • TABLE 19 Frequently used CTC size-based enrichment techniques across clinical settings
  • TABLE 20 FDA approved CTC membrane-based enrichment from whole blood samples across clinical settings
  • TABLE 21 Frequently used CTC microfluidics-based enrichment techniques across clinical settings
  • TABLE 22 FDA-approved CTC density-based enrichment techniques from whole blood samples across clinical settings
  • TABLE 23 FDA-approved CTC combination-based enrichment techniques from whole blood samples across clinical settings
  • TABLE 24 List of companies working on microfluidic-based CTC analysis
  • TABLE 25 North America CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 26 North America CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 27 North America CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 28 North America CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 29 North America CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 30 North America CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 31 North America CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 32 North America CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 33 North America CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 34 North America CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 35 U.S. CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 36 U.S. CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 37 U.S. CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 38 U.S. CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 39 U.S. CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 40 U.S. CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 41 U.S. CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 42 U.S. CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 43 U.S. CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 44 U.S. CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 45 Canada CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 46 Canada CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 47 Canada CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 48 Canada CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 49 Canada CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 50 Canada CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 51 Canada CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 52 Canada CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 53 Canada CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 54 Canada CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 55 Europe CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 56 Europe CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 57 Europe CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 58 Europe CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 59 Europe CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 60 Europe CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 61 Europe CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 62 Europe CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 63 Europe CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 64 Europe CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 65 Germany CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 66 Germany CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 67 Germany CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 68 Germany CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 69 Germany CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 70 Germany CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 71 Germany CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 72 Germany CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 73 Germany CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 74 Germany CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 75 U.K. CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 76 U.K. CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 77 U.K. CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 78 U.K. CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 79 U.K. CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 80 U.K. CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 81 U.K. CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 82 U.K. CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 83 U.K. CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 84 U.K. CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 85 France CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 86 France CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 87 France CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 88 France CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 89 France CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 90 France CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 91 France CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 92 France CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 93 France CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 94 France CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 95 Spain CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 96 Spain CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 97 Spain CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 98 Spain CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 99 Spain CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 100 Spain CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 101 Spain CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 102 Spain CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 103 Spain CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 104 Spain CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 105 Italy CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 106 Italy CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 107 Italy CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 108 Italy CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 109 Italy CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 110 Italy CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 111 Italy CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 112 Italy CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 113 Italy CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 114 Italy CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 115 Asia Pacific CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 116 Asia Pacific CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 117 Asia Pacific CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 118 Asia Pacific CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 119 Asia Pacific CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 120 Asia Pacific CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 121 Asia Pacific CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 122 Asia Pacific CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 123 Asia Pacific CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 124 Asia Pacific CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 125 Japan CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 126 Japan CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 127 Japan CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 128 Japan CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 129 Japan CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 130 Japan CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 131 Japan CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 132 Japan CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 133 Japan CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 134 Japan CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 135 China CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 136 China CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 137 China CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 138 China CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 139 China CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 140 China CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 141 China CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 142 China CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 143 China CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 144 China CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 145 India CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 146 India CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 147 India CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 148 India CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 149 India CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 150 India CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 151 India CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 152 India CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 153 India CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 154 India CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 155 South Korea CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 156 South Korea CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 157 South Korea CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 158 South Korea CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 159 South Korea CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 160 South Korea CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 161 South Korea CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 162 South Korea CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 163 South Korea CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 164 South Korea CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 165 Singapore CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 166 Singapore CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 167 Singapore CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 168 Singapore CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 169 Singapore CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 170 Singapore CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 171 Singapore CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 172 Singapore CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 173 Singapore CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 174 Singapore CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 175 Australia CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 176 Australia CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 177 Australia CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 178 Australia CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 179 Australia CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 180 Australia CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 181 Australia CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 182 Australia CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 183 Australia CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 184 Australia CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 185 Latin America CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 186 Latin America CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 187 Latin America CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 188 Latin America CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 189 Latin America CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 190 Latin America CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 191 Latin America CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 192 Latin America CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 193 Latin America CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 194 Latin America CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 195 Brazil CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 196 Brazil CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 197 Brazil CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 198 Brazil CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 199 Brazil CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 200 Brazil CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 201 Brazil CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 202 Brazil CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 203 Brazil CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 204 Brazil CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 205 Argentina CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 206 Argentina CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 207 Argentina CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 208 Argentina CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 209 Argentina CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 210 Argentina CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 211 Argentina CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 212 Argentina CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 213 Argentina CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 214 Argentina CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 215 MEA CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 216 MEA CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 217 MEA CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 218 MEA CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 219 MEA CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 220 MEA CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 221 MEA CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 222 MEA CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 223 MEA CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 224 MEA CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 225 South Africa CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 226 South Africa CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 227 South Africa CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 228 South Africa CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 229 South Africa CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 230 South Africa CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 231 South Africa CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 232 South Africa CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 233 South Africa CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 234 South Africa CTC market, by specimen, 2016 - 2027 (USD Million)
  • TABLE 235 UAE CTC market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 236 UAE CTC market for detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 237 UAE CTC market for immunocapture-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 238 UAE CTC market for size-based detection & enrichment methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 239 UAE CTC market for direct detection methods estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • TABLE 240 UAE CTC market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 241 UAE CTC market for clinical-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 242 UAE CTC market for research-use estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 243 UAE CTC market, by product, 2016 - 2027 (USD Million)
  • TABLE 244 UAE CTC market, by specimen, 2016 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value-chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market model for CTC market
  • FIG. 8 Product offerings in the market
  • FIG. 9 Market model for CTC market, by technology
  • FIG. 10 Penetration of molecules in liquid biopsy market
  • FIG. 11 Penetration of molecules in liquid biopsy market
  • FIG. 12 Regional analysis for CTCs penetration in therapy selection
  • FIG. 13 Regional analysis for CTCs penetration in disease diagnosis
  • FIG. 14 Market summary (USD Million, 2019)
  • FIG. 15 Molecular applications of liquid biopsy for personalized medicine
  • FIG. 16 Market driver relevance analysis (Current & future impact)
  • FIG. 17 Application of circulating tumor cell in prostate cancer
  • FIG. 18 Global cancer incidence, as of September 2018
  • FIG. 19 Market restraint relevance analysis (Current & future impact)
  • FIG. 20 Penetration & growth prospect mapping, technology, 2019
  • FIG. 21 Impact analysis by key companies, 2019
  • FIG. 22 Company categorization
  • FIG. 23 Key customers
  • FIG. 24 Heat map analysis of top key players, 2019
  • FIG. 25 Public companies market position analysis, 2019
  • FIG. 26 Competitive dashboard analysis for public players
  • FIG. 27 Circulating tumor cells (CTC) market: Technology outlook key takeaways
  • FIG. 28 Percentage of clinical studies utilizing specific isolation markers, 1999 - 2017
  • FIG. 29 Percentage of specific enrichment/analysis techniques, 1999 - 2017
  • FIG. 30 Circulating tumor cells (CTC) market: Technology market movement analysis
  • FIG. 31 Global CTC enrichment & detection market, 2016 - 2027 (USD Million)
  • FIG. 32 Global immunocapture (label-based) CTC market, 2016 - 2027 (USD Million)
  • FIG. 33 Global immunocapture/label-based positive selection market, 2016 - 2027 (USD Million)
  • FIG. 34 Global immunocapture/label-based negative selection market, 2016 - 2027 (USD Million)
  • FIG. 35 Global size-based separation (label-free) CTC market, 2016 - 2027 (USD Million)
  • FIG. 36 Global membrane-based size separation (label-free) CTC market, 2016 - 2027 (USD Million)
  • FIG. 37 Global microfluidic-based size separation (label-free) CTC market, 2016 - 2027 (USD Million)
  • FIG. 38 Global density-based separation (label-free) CTC market, 2016 - 2027 (USD Million)
  • FIG. 39 Global combined methods (label-free) CTC market, 2016 - 2027 (USD Million)
  • FIG. 40 Global CTC direct detection market, 2016 - 2027 (USD Million)
  • FIG. 41 Global CTC microscopy direct detection market, 2016 - 2027 (USD Million)
  • FIG. 42 Global CTC SERS direct detection market, 2016 - 2027 (USD Million)
  • FIG. 43 Global CTC other direct detection market, 2016 - 2027 (USD Million)
  • FIG. 44 Global CTC analysis & downstream assays market, 2016 - 2027 (USD Million)
  • FIG. 45 Global circulating tumor cell market: Application outlook key takeaways
  • FIG. 46 Circulating tumor cells market: Application movement analysis
  • FIG. 47 Circulating tumor cells market for clinical/liquid biopsy, 2016 - 2027 (USD Million)
  • FIG. 48 Circulating tumor cells market for risk assessment, 2016 - 2027 (USD Million)
  • FIG. 49 Circulating tumor cells market for screening and monitoring, 2016 - 2027 (USD Million)
  • FIG. 50 Application of CTCs in personalized medicine
  • FIG. 51 Circulating tumor cells market for research, 2016 - 2027 (USD Million)
  • FIG. 52 Circulating tumor cells market for cancer stem cell & tumorgenesis research, 2016 - 2027 (USD Million)
  • FIG. 53 Single-cell analysis of CTCs address tumor heterogeneity
  • FIG. 54 Circulating tumor cells market for drug/therapy development, 2016 - 2027 (USD Million)
  • FIG. 55 Global circulating tumor cell market: Product outlook key takeaways
  • FIG. 56 Circulating tumor cells market: Product movement analysis
  • FIG. 57 Global devices or systems market, 2016 - 2027 (USD Million)
  • FIG. 58 Global kits and reagents market, 2016 - 2027 (USD Million)
  • FIG. 59 Global blood collection tubes market, 2016 - 2027 (USD Million)
  • FIG. 60 Global circulating tumor cell market: Specimen outlook key takeaways
  • FIG. 61 Circulating tumor cells market: Specimen movement analysis
  • FIG. 62 Global blood-based CTC specimen market, 2016 - 2027 (USD Million)
  • FIG. 63 Global bone marrow-based CTC specimen market, 2016 - 2027 (USD Million)
  • FIG. 64 Global other body fluids-based CTC specimen market, 2016 - 2027 (USD Million)
  • FIG. 65 Global Circulating Tumor Cell (CTC) market: Regional key takeaways
  • FIG. 66 Circulating Tumor Cell (CTC) market: Regional movement analysis
  • FIG. 67 North America Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 68 U.S. Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 69 Canada Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 70 Europe Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 71 Germany Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 72 U.K. Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 73 France Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 74 Spain Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 75 Italy Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 76 Asia Pacific Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 77 Japan Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 78 China Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 79 India Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 80 South Korea Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 81 Singapore Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 82 Australia Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 83 Latin America Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 84 Brazil Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 85 Argentina Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 86 MEA Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 87 South Africa Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
  • FIG. 88 UAE Circulating Tumor Cell (CTC) market, 2016 - 2027 (USD Million)
Back to Top